All posts by : Felistas

Older adults diagnosed with dementia lose their ability to assess how well they manage their finances, according to a recent study I co-authored in The Gerontologist. In comparison, people of the same age who don’t have dementia are aware of their financial abilities—and this awareness improves over time.

The word “crisis” is used frequently and, I would argue, inaccurately, to depict the psychological well-being of today’s college students.

Pancreatic cancer is a severe illness and major challenge in cancer medicine since it is difficult to diagnose, while potential therapies are scarce. A new international cooperation study indicates that in the future pancreatic cancer may be detected at an early stage from gut microbes. Gut microbes may also offer solutions for therapy development.

Diseases caused by human papillomavirus (HPV), such as cervical cancer, may have a new treatment option thanks to a technology developed by researchers at Imunotera Soluções Terapêuticas, a São Paulo startup incubated at Eretz.bio, the biotechnology startup hub at Albert Einstein Jewish Brazilian Hospital.

A blood-based test has acceptable accuracy for colorectal cancer detection but not for advanced precancerous lesions in an average-risk colorectal cancer screening population, according to a study published online June 2 in the Journal of the American Medical Association.

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants.

When someone has high blood pressure, or hypertension, it results in changes to the walls of their blood vessels. This process is known as arterial or vascular remodeling, which is driven by smooth muscle cells in the blood vessel wall. Researchers at Michigan Medicine have uncovered a key mechanism that regulates blood pressure and vascular remodeling—increasing downstream risk of heart attack and stroke—in people with a genetic variant linked to high blood pressure, a study in both animals and human samples suggests.

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children’s Research Hospital and University College London today report thirteen years of follow-up data. Hemophilia B is a rare genetic disorder caused by insufficient levels of a circulating protein called factor IX, which promotes blood clotting.

A study led by the Sant Pau Research Institute (IR Sant Pau) has succeeded in describing, for the first time in detail, the structural evolution of the medial temporal lobe (MTL) regions across the clinical stages of Alzheimer’s disease in people with Down syndrome. The results, published in the journal Brain, reveal that volume and cortical thickness loss in these regions can begin 13 to 15 years before the onset of symptoms, marking a significant advance in early diagnosis and the design of preventive clinical trials.

An international study published today in the New England Journal of Medicine sheds light on acute normovolemic hemodilution, also known as ANH, a blood conservation technique.